Back to Market Feed

Product Information

GLIPIZIDE-METFORMIN 5-500 MG is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.1981 per EA under NDC 23155011701. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jun 23, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GLIPIZIDE-METFORMIN 5-500 MG

Glipizide and Metformin HCl
$0.1981per EA

Strength

5; 500 mg/1; mg/1

NDC

23155011701

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078728

FDA Approved

6/23/2010

TE Code

AB

On Market Since

6/29/2010

Pharmacological Classes

Biguanide
Biguanides
Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIPIZIDE-METFORMIN 5-500 MG has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1981 per EA
All-time high$0.5324 (Feb 10, 2016)
All-time low$0.1588 (Jul 21, 2021)
52-week high$0.2224
52-week low$0.1910
Median price$0.2711
Average price$0.3023
Largest weekly change+60.0% (Feb 23, 2022)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+3.7%

1M

+3.7%

3M

-2.8%

6M

-9.5%

1Y

-8.4%

3Y

-24.9%

5Y

+8.8%

All

-50.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Glipizide and Metformin HCl market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

METFORMIN HCL 500 MG TABLET
Generic
71093013204•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
71093013205•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
71093013206•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
00378718505•Mylan Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
00904716261•Major Pharmaceuticals
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084101•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084105•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084110•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094701•Laurus Labs Limited
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094705•Laurus Labs Limited
$0.0142
per EA

Frequently asked questions

What is the NADAC price of GLIPIZIDE-METFORMIN 5-500 MG?

The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 5-500 MG, manufactured by Heritage Pharmaceuticals Inc., is $0.1981 per EA (NDC 23155011701), effective Aug 19, 2026.

How has the price of GLIPIZIDE-METFORMIN 5-500 MG changed over time?

Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 5-500 MG has declined 50.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 5-500 MG?

Since Nov 28, 2013, the NADAC for GLIPIZIDE-METFORMIN 5-500 MG has ranged from a low of $0.1588 (Jul 21, 2021) to a high of $0.5324 (Feb 10, 2016), with a median of $0.2711 per EA.

Are there cheaper alternatives to GLIPIZIDE-METFORMIN 5-500 MG?

No other NADAC-published product currently shares the active ingredient and strength of GLIPIZIDE-METFORMIN 5-500 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GLIPIZIDE-METFORMIN 5-500 MG?

GLIPIZIDE-METFORMIN 5-500 MG (NDC 23155011701) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.